The current state of Hologic (NASDAQ:HOLX) is summed up well by Amit Hazan of SunTrust Banks in an article on Firstwordmedtech.com. Mr. Hazan stated "I just don't see a pathway forward that could happen without the equity really getting hurt." This article will explain how Hologic has destroyed shareholder value in the past at an extreme level. We will also explain how this may be occurring again right now. At this point, if an investor is still long Hologic, they need to consider whether there are better investments available to them then Hologic and whether the risk, which is obviously high, outweighs any significant potential return on investment, which is not likely to be seen until at least...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|